345 related articles for article (PubMed ID: 29866816)
1. Activated protein C, protease activated receptor 1, and neuroprotection.
Griffin JH; Zlokovic BV; Mosnier LO
Blood; 2018 Jul; 132(2):159-169. PubMed ID: 29866816
[TBL] [Abstract][Full Text] [Related]
2. 2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C.
Griffin JH; Mosnier LO; Fernández JA; Zlokovic BV
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2143-2151. PubMed ID: 27758767
[TBL] [Abstract][Full Text] [Related]
3. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.
Mosnier LO; Sinha RK; Burnier L; Bouwens EA; Griffin JH
Blood; 2012 Dec; 120(26):5237-46. PubMed ID: 23149848
[TBL] [Abstract][Full Text] [Related]
4. Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity.
Wang Y; Thiyagarajan M; Chow N; Singh I; Guo H; Davis TP; Zlokovic BV
Stroke; 2009 May; 40(5):1864-9. PubMed ID: 19057019
[TBL] [Abstract][Full Text] [Related]
5. Activated protein C analog promotes neurogenesis and improves neurological outcome after focal ischemic stroke in mice via protease activated receptor 1.
Wang Y; Zhao Z; Chow N; Ali T; Griffin JH; Zlokovic BV
Brain Res; 2013 Apr; 1507():97-104. PubMed ID: 23438513
[TBL] [Abstract][Full Text] [Related]
6. Protection of ischemic white matter and oligodendrocytes in mice by 3K3A-activated protein C.
Huuskonen MT; Wang Y; Nikolakopoulou AM; Montagne A; Dai Z; Lazic D; Sagare AP; Zhao Z; Fernandez JA; Griffin JH; Zlokovic BV
J Exp Med; 2022 Jan; 219(1):. PubMed ID: 34846535
[TBL] [Abstract][Full Text] [Related]
7. Species-dependent neuroprotection by activated protein C mutants with reduced anticoagulant activity.
Guo H; Wang Y; Singh I; Liu D; Fernández JA; Griffin JH; Chow N; Zlokovic BV
J Neurochem; 2009 Apr; 109(1):116-24. PubMed ID: 19166505
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity.
Guo H; Singh I; Wang Y; Deane R; Barrett T; Fernández JA; Chow N; Griffin JH; Zlokovic BV
Eur J Neurosci; 2009 Mar; 29(6):1119-30. PubMed ID: 19302148
[TBL] [Abstract][Full Text] [Related]
9. Activated protein C in neuroprotection and malaria.
Mosnier LO
Curr Opin Hematol; 2019 Sep; 26(5):320-330. PubMed ID: 31348046
[TBL] [Abstract][Full Text] [Related]
10. 3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice.
Wang Y; Zhao Z; Rege SV; Wang M; Si G; Zhou Y; Wang S; Griffin JH; Goldman SA; Zlokovic BV
Nat Med; 2016 Sep; 22(9):1050-5. PubMed ID: 27548576
[TBL] [Abstract][Full Text] [Related]
11. PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke.
Sinha RK; Wang Y; Zhao Z; Xu X; Burnier L; Gupta N; Fernández JA; Martin G; Kupriyanov S; Mosnier LO; Zlokovic BV; Griffin JH
Blood; 2018 Mar; 131(11):1163-1171. PubMed ID: 29343482
[TBL] [Abstract][Full Text] [Related]
12. An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway.
Guo H; Zhao Z; Yang Q; Wang M; Bell RD; Wang S; Chow N; Davis TP; Griffin JH; Goldman SA; Zlokovic BV
J Neurosci; 2013 Apr; 33(14):6181-90. PubMed ID: 23554499
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E Receptor 2 Mediates Activated Protein C-Induced Endothelial Akt Activation and Endothelial Barrier Stabilization.
Sinha RK; Yang XV; Fernández JA; Xu X; Mosnier LO; Griffin JH
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):518-24. PubMed ID: 26800564
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1.
Thiyagarajan M; Fernández JA; Lane SM; Griffin JH; Zlokovic BV
J Neurosci; 2008 Nov; 28(48):12788-97. PubMed ID: 19036971
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C: biased for translation.
Griffin JH; Zlokovic BV; Mosnier LO
Blood; 2015 May; 125(19):2898-907. PubMed ID: 25824691
[TBL] [Abstract][Full Text] [Related]
16. C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities.
Yamashita A; Zhang Y; Sanner MF; Griffin JH; Mosnier LO
J Thromb Haemost; 2020 May; 18(5):1027-1038. PubMed ID: 32017367
[TBL] [Abstract][Full Text] [Related]
17. Cytoprotective-selective activated protein C therapy for ischaemic stroke.
Mosnier LO; Zlokovic BV; Griffin JH
Thromb Haemost; 2014 Nov; 112(5):883-92. PubMed ID: 25230930
[TBL] [Abstract][Full Text] [Related]
18. Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury.
Gleeson EM; Dichiara MG; Salicio A; Quinn LM; Drakeford C; Russell SE; Walsh PT; Orbe J; Hermida J; Smith OP; O'Donnell JS; Montes R; Preston RJ
Blood; 2015 Aug; 126(7):915-9. PubMed ID: 26084674
[TBL] [Abstract][Full Text] [Related]
19. Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.
Lyden P; Pryor KE; Coffey CS; Cudkowicz M; Conwit R; Jadhav A; Sawyer RN; Claassen J; Adeoye O; Song S; Hannon P; Rost NS; Hinduja A; Torbey M; Lee JM; Benesch C; Rippee M; Rymer M; Froehler MT; Clarke Haley E; Johnson M; Yankey J; Magee K; Qidwai J; Levy H; Mark Haacke E; Fawaz M; Davis TP; Toga AW; Griffin JH; Zlokovic BV;
Ann Neurol; 2019 Jan; 85(1):125-136. PubMed ID: 30450637
[TBL] [Abstract][Full Text] [Related]
20. Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.
Mosnier LO; Zampolli A; Kerschen EJ; Schuepbach RA; Banerjee Y; Fernández JA; Yang XV; Riewald M; Weiler H; Ruggeri ZM; Griffin JH
Blood; 2009 Jun; 113(23):5970-8. PubMed ID: 19244160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
